Literature DB >> 12627231

Mutant dynactin in motor neuron disease.

Imke Puls1, Catherine Jonnakuty, Bernadette H LaMonte, Erika L F Holzbaur, Mariko Tokito, Eric Mann, Mary Kay Floeter, Kimberly Bidus, Dennis Drayna, Shin J Oh, Robert H Brown, Christy L Ludlow, Kenneth H Fischbeck.   

Abstract

Impaired axonal transport in motor neurons has been proposed as a mechanism for neuronal degeneration in motor neuron disease. Here we show linkage of a lower motor neuron disease to a region of 4 Mb at chromosome 2p13. Mutation analysis of a gene in this interval that encodes the largest subunit of the axonal transport protein dynactin showed a single base-pair change resulting in an amino-acid substitution that is predicted to distort the folding of dynactin's microtubule-binding domain. Binding assays show decreased binding of the mutant protein to microtubules. Our results show that dysfunction of dynactin-mediated transport can lead to human motor neuron disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12627231     DOI: 10.1038/ng1123

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  314 in total

1.  A high-throughput screening method for small-molecule inhibitors of the aberrant mutant SOD1 and dynein complex interaction.

Authors:  Xiaohu Tang; Kathleen I Seyb; Mickey Huang; Eli R Schuman; Ping Shi; Haining Zhu; Marcie A Glicksman
Journal:  J Biomol Screen       Date:  2011-12-01

Review 2.  Myelin disorders: Causes and perspectives of Charcot-Marie-Tooth neuropathy.

Authors:  Gerd Meyer zu Hörste; Thomas Prukop; Klaus-Armin Nave; Michael W Sereda
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

Review 3.  Complex genetics of amyotrophic lateral sclerosis.

Authors:  Catherine B Kunst
Journal:  Am J Hum Genet       Date:  2004-10-11       Impact factor: 11.025

4.  Effects of diet on synaptic vesicle release in dynactin complex mutants: a mechanism for improved vitality during motor disease.

Authors:  Joel M Rawson; Tabita Kreko; Holly Davison; Rebekah Mahoney; Alex Bokov; Leo Chang; Jon Gelfond; Greg T Macleod; Benjamin A Eaton
Journal:  Aging Cell       Date:  2012-02-22       Impact factor: 9.304

5.  Multiple modes of cytoplasmic dynein regulation.

Authors:  Richard B Vallee; Richard J McKenney; Kassandra M Ori-McKenney
Journal:  Nat Cell Biol       Date:  2012-02-29       Impact factor: 28.824

6.  Defects in mitochondrial axonal transport and membrane potential without increased reactive oxygen species production in a Drosophila model of Friedreich ataxia.

Authors:  Yujiro Shidara; Peter J Hollenbeck
Journal:  J Neurosci       Date:  2010-08-25       Impact factor: 6.167

Review 7.  Retrograde axonal transport: pathways to cell death?

Authors:  Eran Perlson; Sandra Maday; Meng-Meng Fu; Armen J Moughamian; Erika L F Holzbaur
Journal:  Trends Neurosci       Date:  2010-04-29       Impact factor: 13.837

8.  Dysregulation of a novel miR-1825/TBCB/TUBA4A pathway in sporadic and familial ALS.

Authors:  Anika M Helferich; Sarah J Brockmann; Jörg Reinders; Dhruva Deshpande; Karlheinz Holzmann; David Brenner; Peter M Andersen; Susanne Petri; Dietmar R Thal; Jens Michaelis; Markus Otto; Steffen Just; Albert C Ludolph; Karin M Danzer; Axel Freischmidt; Jochen H Weishaupt
Journal:  Cell Mol Life Sci       Date:  2018-07-20       Impact factor: 9.261

9.  The Drosophila BEACH family protein, blue cheese, links lysosomal axon transport with motor neuron degeneration.

Authors:  Angeline Lim; Rachel Kraut
Journal:  J Neurosci       Date:  2009-01-28       Impact factor: 6.167

Review 10.  Microtubule-stabilizing agents as potential therapeutics for neurodegenerative disease.

Authors:  Kurt R Brunden; John Q Trojanowski; Amos B Smith; Virginia M-Y Lee; Carlo Ballatore
Journal:  Bioorg Med Chem       Date:  2013-12-30       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.